Hepatitis B virus X protein disrupts DNA interstrand crosslinking agent mitomycin C induced ATR dependent intra-S-phase checkpoint

European Journal of Cancer

Volumn 44, Issue 11, 2008, Pages 1596-1602

  Wu, Xiao Ye ^a   Qian, Jia Jie ^b   Lin, Yi ^c   Zheng, Ming Hua ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Chk1; DNA interstrand crosslink (ICL); FANCD2; Hepatitis B virus X protein; Intra S phase checkpoint

Indexed keywords

ATR PROTEIN; CHECKPOINT KINASE 1; DNA; FANCONI ANEMIA GROUP D2 PROTEIN; HEPATITIS B VIRUS X PROTEIN; MITOMYCIN C;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; DNA REPAIR; DNA SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CARCINOMA, HEPATOCELLULAR; DNA DAMAGE; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MITOMYCIN; NUCLEIC ACID SYNTHESIS INHIBITORS; PROTEIN KINASES; S PHASE; TRANS-ACTIVATORS;

EID: 46049113873     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.04.012     Document Type: Article

References (30)

1. Ganem D., and Prince A.M. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 350 (2004) 1118-1129
2. Feitelson M.A., Zhu M., Duan L.X., et al. Hepatitis B-x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8 (1993) 1109-1117
3. Pang R., Tse E., and Poon T.P.R. Molecular pathways in hepatocellular carcinoma. Cancer lett 240 (2006) 157-169
4. Bouchard M., Giannakopoulos S., Wang E.H., et al. Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway. J Virol 75 (2001) 4247-4257
5. Klein A., Guhl E., Tzeng Y.J., et al. HBx causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53. Oncogene 22 (2003) 2910-2919
6. Livezey K.W., Negorev D., and Simon D. Increased chromosomal alterations and micronuclei formation in human hepatoma HepG2 cells transfected with the hepatitis B virus HBX gene. Mutat Res 505 (2002) 63-74
7. Mathonnet G., Lachance S., Alaoui-Jamali M., et al. Expression of hepatitis B virus X oncoprotein inhibits transcription-coupled nucleotide excision repair in human cells. Mutat Res 554 (2004) 305-318
8. Groisman I.J., Koshy R., Henkler F., et al. Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53 -deficient cells. Carcinogenesis 20 (1999) 479-483
9. Becker S.A., Lee T.H., Butel J.S., et al. Hepatitis B virus X protein interferes with cellular DNA repair. J Virol 72 (1998) 266-272
10. Zheng H., Wang X., Warren A.J., et al. Nucleotide excision repair- and polymerase η-mediated error-prone removal of mitomycin C interstrand cross-links. Mol Cell Biol 23 (2003) 754-761
11. Lambert S., and Carr A.M. Checkpoint responses to replication fork barriers. Biochimie 87 (2005) 591-602
12. Petermann E., and Caldecott K.W. Evidence that the ATR / Chk1 1 pathway maintains normal replication fork progression during unperturbed S phase. Cell Cycle 5 (2006) 2203-2209
13. Bartek J., Lukas C., and Lukas J. Checking on DNA damage in S phase. Nat Rev Mol Cell Biol 5 (2004) 792-804
14. Näf D., Kupfer G.M., Suliman A., et al. Functional activity of the fanconi anemia protein FAA requires FAC binding and nuclear localization. Mol Cell Biol 18 (1998) 5952-5960
15. Falck J., Petrini J.H., Williams B.R., et al. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat Genet 30 (2002) 290-294
16. Nieborowska-Skorska M., Stoklosa T., Datta M., et al. ATR-Chk1 axis protects BCR/ABL leukemia cells from the lethal effect of DNA double-strand breaks. Cell Cycle 5 (2006) 994-1000
17. Howlett N.G., Taniguchi T., Durkin S.G., et al. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genet 14 (2005) 693-701
18. Pichierr P., and Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J 23 (2004) 1178-1187
19. Bontron S., Lin-Marq N., and Strubin M. Hepatitis B virus X protein associated with UV-DDB1 induces cell death in the nucleus and is functionally antagonized by UV-DDB2. J Biol Chem 277 (2002) 38847-38854
20. Dronkert M.L., and Kanaar R. Repair of DNA interstrand cross-links. Mutat Res 486 (2001) 217-247
21. Zhou B.B., and Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 408 (2000) 433-439
22. Mladenov E., Tsaneva I., and Anachkova B. Activation of the S phase DNA damage checkpoint by mitomycin C. J Cell Physiol 211 (2007) 468-476
23. Kupfer G.M., and D'Andrea A.D. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation. Blood 88 (1996) 1019-1025
24. Yun J., Zhong Q., Kwak J.Y., et al. Hypersensitivity of Brca1 -deficient MEF to the DNA interstrand crosslinking agent mitomycin C is associated with defect in homologous recombination repair and aberrant S-phase arrest. Oncogene 24 (2005) 4009-4016
25. Jirmanova L., Bulavin D.V., and Fornace Jr. A.J. Inhibition of the ATR/Chk1 pathway induces a p38-dependent S-phase delay in mouse embryonic stem cells. Cell Cycle 4 (2005) 1428-1434
26. Seiler J.A., Conti C., Syed A., et al. The intra-S-phase checkpoint affects both DNA replication initiation and elongation: Single-cell and -DNA fiber analyses. Mol Cell Biol 27 (2007) 5806-5818
27. Lam M.H., and Rosen J.M. Chk1 versus Cdc25: chking one's levels of cellular proliferation. Cell Cycle 3 (2004) 1355-1357
28. Garcia-Higuera I., Taniguchi T., Ganesan S., et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 7 (2001) 249-262
29. Wang X., Andreassen P.R., and D'Andrea A.D. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol Cell Biol 24 (2004) 5850-5862
30. Clevers H. At the crossroads of inflammation and cancer. Cell 118 (2004) 671-674